药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Hydroxypropyl cellulose
Eliglustat
The metabolism of Metoclopramide can be decreased when combined with Eliglustat.
Hydroxypropyl cellulose
Levosalbutamol
The metabolism of Levosalbutamol can be decreased when combined with Metoclopramide.
Hydroxypropyl cellulose
Dimethyl sulfoxide
The metabolism of Metoclopramide can be decreased when combined with Dimethyl sulfoxide.
Hydroxypropyl cellulose
Isotretinoin
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isotretinoin is combined with Metoclopramide.
Hydroxypropyl cellulose
Colchicine
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Colchicine.
Hydroxypropyl cellulose
Fenofibric acid
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Fenofibric acid.
Hydroxypropyl cellulose
Clofibride
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Clofibride.
Hydroxypropyl cellulose
Aluminium clofibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Aluminium clofibrate.
Hydroxypropyl cellulose
Ronifibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Ronifibrate.
Hydroxypropyl cellulose
Simfibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Simfibrate.
Hydroxypropyl cellulose
Emetine
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Emetine.
Hydroxypropyl cellulose
Ubidecarenone
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Ubidecarenone.
Hydroxypropyl cellulose
Ciprofibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Ciprofibrate.
Hydroxypropyl cellulose
Acipimox
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Acipimox.
Hydroxypropyl cellulose
Etofibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Etofibrate.
Hydroxypropyl cellulose
Pitavastatin
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Pitavastatin.
Hydroxypropyl cellulose
Raltegravir
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Raltegravir.
Hydroxypropyl cellulose
Mevastatin
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Mevastatin.
Hydroxypropyl cellulose
Bezafibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Bezafibrate.
Hydroxypropyl cellulose
Docetaxel
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Docetaxel.